Public Assessment Report Esomeprazole 20 mg gastro ...

The Human Medicines Regulations 2012 – …

The Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …

  Human, Regulations, Descriptions, Medicine, 2012, Human medicines regulations 2012, Human medicines regulations 2012 description of

FULTIUM -D 800 IU CAPSULES - GOV.UK

Vitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption

  Deficiency, Capsule, Vitamin, Fultium d 800 iu capsules, Fultium, Vitamin d deficiency

GLYCOPYRRONIUM BROMIDE 0.2MG/ML …

UKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)

  Solutions, Injection, 0115, Solution for injection pl 00156, 00156, Solution for injection, Pl 00156

Meloxicam - GOV.UK

PL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted

  15mg, Meloxicam

PL 00010/0643 - GOV.UK

UKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-

  Excipients, 3460, Pl 00010 0643, 00010

Public Assessment Report UKPAR Canesten Combi …

This is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).

DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...

PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure

  Solutions

Public Assessment Report Mutual Recognition …

PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION

  Assessment, Report, Public, Procedures, Mutual, Recognition, Public assessment report mutual recognition, Public assessment report mutual recognition procedure

Cefixime 400 mg Film-coated Tablets, PL 22805 …

MHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …

  Cefixime

Public Assessment Report Decentralised Procedure …

Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC

  Assessment, Report, Public, Procedures, Public assessment report decentralised procedure, Decentralised

New Zealand Data Sheet Pantoprazole Actavis - Medsafe

New Zealand Data Sheet Pantoprazole Actavis Pantoprazole Sodium Sesquihydrate, enteric coated tablets, 20 mg and 40 mg (as pantoprazole) Presentation

  Sheet, Data, Tablets, Zealand, New zealand data sheet pantoprazole actavis, Pantoprazole, Actavis

Regulatory Expectations of Presentation of Dissolution Data

Safeguarding public health Regulatory Expectations of Presentation of Dissolution Data David Darling Pharmaceutical Assessor Medicines and Healthcare products

  Regulatory, Presentation, Expectations, Regulatory expectations of presentation of

Diclofenac Sodium 50 mg Gastro-resistant tablets

V_1363 Children These tablets are not suitable for children aged under 12. The doctor may also prescribe another drug to protect the stomach to be taken at the same time,

  Tablets, Resistant, Gastro, Mg gastro resistant tablets

SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi

SUMMARY OF PRODUCT CHARACTERISTICS 1 Name of the medicinal product Depakote 250mg Tablets. Depakote 500mg Tablets. 2 Qualitative and quantitative composition

  Product, Summary, Tablets, Characteristics, Summary of product characteristics

PATIENT INFORMATION LEAFLET Aspirin 300mg

PIL UK 003 PATIENT INFORMATION LEAFLET Aspirin 300mg Gastro-resistant Tablets (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine

  Tablets, Resistant, Gastro, Resistant tablets

Drugs approved from 1st Jan 2014 to 31 december 2014 Drug ...

Drugs approved from 1st Jan 2014 to 31 december 2014 S.No Drug Indication Date For the treatment of overactive bladder with Tolterodine Tartrate Extended release symptoms of urge urinary

  Date, Treatment, Indications, Indication date for the treatment

Approval Status of New Drug during 1971-1981

Approval Status of New Drug during 1971-1981 S. No Drug Indication Date of Approval 1. Hydroxyurea USP Tablet 200 mg Anti-neoplastic agent Jan,1971

  Drug, During, Status, Approval, Approval status of new drug during

Public Assessment Report - GOV.UK

PAR Acamprosate 333 mg Gastro-resistant Tablets UK/H/5445/001/DC 7 II QUALITY ASPECTS II.1 Introduction This product is a gastro-resistant tablet and contains 333.0 mg of …

  Assessment, Report, Public, Tablets, Resistant, Public assessment report, Gastro, Mg gastro resistant tablets

New Zealand Datasheet Name of Medicine - Medsafe

General Instructions Pantoprazole gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with some liquid. For eradication of H. pylori, convenient dosing

  Datasheet, Name, Medicine, Tablets, Resistant, Zealand, New zealand datasheet name of medicine, Gastro, Resistant tablets